AAAAAA

   
Results: 1-16 |
Results: 16
In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates
Authors: Milenic, DE Roselli, M Mirzadeh, S Pippin, CG Gansow, OA Colcher, D Brechbiel, MW Schlom, J
Citation: De. Milenic et al., In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates, CANC BIO R, 16(2), 2001, pp. 133-146
Evaluation of Ac-225 for vascular targeted radioimmunotherapy of lung tumors
Authors: Kennel, SJ Chappell, LL Dadachova, K Brechbiel, MW Lankford, TK Davis, IA Stabin, M Mirzadeh, S
Citation: Sj. Kennel et al., Evaluation of Ac-225 for vascular targeted radioimmunotherapy of lung tumors, CANC BIO R, 15(3), 2000, pp. 235-244
Labeling and distribution of linear peptides identified using in vivo phage display selection for tumors
Authors: Kennel, SJ Mirzadeh, S Hurst, GB Foote, LJ Lankford, TK Glowienka, KA Chappell, LL Kelso, JR Davern, SM Safavy, A Brechbiel, MW
Citation: Sj. Kennel et al., Labeling and distribution of linear peptides identified using in vivo phage display selection for tumors, NUCL MED BI, 27(8), 2000, pp. 815-825
Thermoseparation of neutron-irradiated tungsten from Re and Os
Authors: Mirzadeh, S Du, MT Beets, A Knapp, FF
Citation: S. Mirzadeh et al., Thermoseparation of neutron-irradiated tungsten from Re and Os, IND ENG RES, 39(9), 2000, pp. 3169-3172
Simple new method for effective concentration of Re-188 solutions from alumina-based W-188-Re-188 generator
Authors: Guhlke, S Beets, AL Oetjen, K Mirzadeh, S Biersack, HJ Knapp, FF
Citation: S. Guhlke et al., Simple new method for effective concentration of Re-188 solutions from alumina-based W-188-Re-188 generator, J NUCL MED, 41(7), 2000, pp. 1271-1278
Combination vascular targeted and tumor targeted radioimmunotherapy
Authors: Kennel, SJ Lankford, TK Foote, LJ Davis, IA Boll, RA Mirzadeh, S
Citation: Sj. Kennel et al., Combination vascular targeted and tumor targeted radioimmunotherapy, CANC BIO R, 14(5), 1999, pp. 371-379
In vivo comparison of CHX-DTPA ligand isomers in athymic mice bearing carcinoma xenografts
Authors: Roselli, M Milenic, DE Brechbiel, MW Mirzadeh, S Pippin, CG Gansow, OA Colcher, D Schlom, J
Citation: M. Roselli et al., In vivo comparison of CHX-DTPA ligand isomers in athymic mice bearing carcinoma xenografts, CANC BIO R, 14(3), 1999, pp. 209-220
Comparison of (225) actinium chelates: Tissue distribution and radiotoxicity
Authors: Davis, IA Glowienka, KA Boll, RA Deal, KA Brechbiel, MW Stabin, M Bochsler, PN Mirzadeh, S Kennel, SJ
Citation: Ia. Davis et al., Comparison of (225) actinium chelates: Tissue distribution and radiotoxicity, NUCL MED BI, 26(5), 1999, pp. 581-589
Treatment of lung tumor colonies with Y-90 targeted to blood vessels: Comparison with the alpha-particle emitter Bi-213
Authors: Kennel, SJ Stabin, M Yoriyaz, H Brechbiel, M Mirzadeh, S
Citation: Sj. Kennel et al., Treatment of lung tumor colonies with Y-90 targeted to blood vessels: Comparison with the alpha-particle emitter Bi-213, NUCL MED BI, 26(1), 1999, pp. 149-157
Radiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cells
Authors: Kennel, SJ Stabin, M Roeske, JC Foote, LJ Lankford, PK Terzaghi-Howe, M Patterson, H Barkenbus, J Popp, DM Boll, R Mirzadeh, S
Citation: Sj. Kennel et al., Radiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cells, RADIAT RES, 151(3), 1999, pp. 244-256
In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers
Authors: Cagle, DW Kennel, SJ Mirzadeh, S Alford, JM Wilson, LJ
Citation: Dw. Cagle et al., In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers, P NAS US, 96(9), 1999, pp. 5182-5187
Improved in vivo stability of actinium-225 macrocyclic complexes
Authors: Deal, KA Davis, IA Mirzadeh, S Kennel, SJ Brechbiel, MW
Citation: Ka. Deal et al., Improved in vivo stability of actinium-225 macrocyclic complexes, J MED CHEM, 42(15), 1999, pp. 2988-2992
Production of medical radioisotopes in the ORNL High Flux Isotope Reactor (HFIR) for cancer treatment and arterial restenosis therapy after PTCA
Authors: Knapp, FF Beets, AL Mirzadeh, S Alexander, CW Hobbs, RL
Citation: Ff. Knapp et al., Production of medical radioisotopes in the ORNL High Flux Isotope Reactor (HFIR) for cancer treatment and arterial restenosis therapy after PTCA, CZEC J PHYS, 49, 1999, pp. 799-809
Metallofullerene drug design
Authors: Wilson, LJ Cagle, DW Thrash, TP Kennel, SJ Mirzadeh, S Alford, JM Ehrhardt, GJ
Citation: Lj. Wilson et al., Metallofullerene drug design, COORD CH RE, 192, 1999, pp. 199-207
Toward fullerene-based radiopharmaceuticals: high-yield neutron activationof endohedral Ho-165 metallofullerenes
Authors: Thrash, TP Cagle, DW Alford, JM Wright, K Ehrhardt, GJ Mirzadeh, S Wilson, LJ
Citation: Tp. Thrash et al., Toward fullerene-based radiopharmaceuticals: high-yield neutron activationof endohedral Ho-165 metallofullerenes, CHEM P LETT, 308(3-4), 1999, pp. 329-336
Radioimmunotherapy of micrometastases in lung with vascular targeted Bi-213
Authors: Kennel, SJ Boll, R Stabin, M Schuller, HM Mirzadeh, S
Citation: Sj. Kennel et al., Radioimmunotherapy of micrometastases in lung with vascular targeted Bi-213, BR J CANC, 80(1-2), 1999, pp. 175-184
Risultati: 1-16 |